Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-08-10 Purchase | 2026-08-12 4:46 pm | BlossomHill Therapeutics Inc. | BLSM | GORDON CARL L Director | 625,000 | $16 | $10,000,000 | 2,714,279 (Indirect) | View |
| 2026-08-10 Purchase | 2026-08-12 4:43 pm | BlossomHill Therapeutics Inc. | BLSM | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC Director | 625,000 | $16 | $10,000,000 | 2,714,279 (Indirect) | View |
| 2026-08-10 Purchase | 2026-08-10 6:35 pm | BlossomHill Therapeutics Inc. | BLSM | Schmid John P. Director | 6,000 | $16 | $96,000 | 6,000 (Direct) | View |
| 2026-08-10 Purchase | 2026-08-10 6:32 pm | BlossomHill Therapeutics Inc. | BLSM | Chen Bihua Cormorant Asset Management LP Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Cormorant Private Healthcare Fund V LP Cormorant Private Healthcare Fund VI LP Director 10% Owner | 312,500 | $16 | $5,000,000 | 3,637,938 (Indirect Direct) | View |
| 2026-08-10 Purchase | 2026-08-10 6:27 pm | BlossomHill Therapeutics Inc. | BLSM | Keyes Jason A Chief Financial Officer | 700 | $16 | $11,200 | 57,446 (Direct) | View |
| 2026-08-07 Purchase | 2026-08-10 6:26 pm | BlossomHill Therapeutics Inc. | BLSM | Liptak Vincent Paul General Counsel | 4,700 | $15.89 | $74,700 | 180,660 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-08-10 Conversion | 2026-08-12 4:46 pm | N/A N/A | BlossomHill Therapeutics Inc. | BLSM | GORDON CARL L Director | 2,089,279 | $0 | 2,714,279 (Indirect) | View |
| 2026-08-10 Conversion | 2026-08-12 4:43 pm | N/A N/A | BlossomHill Therapeutics Inc. | BLSM | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC Director | 2,089,279 | $0 | 2,714,279 (Indirect) | View |
| 2026-08-06 Option Award | 2026-08-10 6:33 pm | N/A 2036-08-05 | BlossomHill Therapeutics Inc. | BLSM | GORDON CARL L Director | 23,904 | $0 | 23,904 (Direct) | View |
| 2026-08-10 Conversion | 2026-08-10 6:32 pm | N/A N/A | BlossomHill Therapeutics Inc. | BLSM | Chen Bihua Cormorant Asset Management LP Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Cormorant Private Healthcare Fund V LP Cormorant Private Healthcare Fund VI LP Director 10% Owner | 3,301,534 | $0 | 3,637,938 (Indirect) | View |
| 2026-08-06 Option Award | 2026-08-10 6:32 pm | N/A 2036-08-05 | BlossomHill Therapeutics Inc. | BLSM | Chen Bihua Cormorant Asset Management LP Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Cormorant Private Healthcare Fund V LP Cormorant Private Healthcare Fund VI LP Director 10% Owner | 23,904 | $0 | 3,637,938 (Direct) | View |
| 2026-08-10 Conversion | 2026-08-10 6:29 pm | N/A N/A | BlossomHill Therapeutics Inc. | BLSM | Agrawal Sundeep Director | 578,524 | $0 | 602,428 (Indirect) | View |
| 2026-08-06 Option Award | 2026-08-10 6:29 pm | N/A 2036-08-05 | BlossomHill Therapeutics Inc. | BLSM | Agrawal Sundeep Director | 23,904 | $0 | 602,428 (Direct) | View |
| 2026-08-06 Option Award | 2026-08-10 6:27 pm | N/A 2036-08-05 | BlossomHill Therapeutics Inc. | BLSM | Keyes Jason A Chief Financial Officer | 56,746 | $0 | 57,446 (Direct) | View |
| 2026-08-10 Conversion | 2026-08-10 6:26 pm | N/A N/A | BlossomHill Therapeutics Inc. | BLSM | Liptak Vincent Paul General Counsel | 22,687 | $0 | 180,660 (Indirect) | View |
| 2026-08-06 Option Award | 2026-08-10 6:26 pm | N/A 2036-08-05 | BlossomHill Therapeutics Inc. | BLSM | Liptak Vincent Paul General Counsel | 46,561 | $0 | 180,660 (Direct) | View |
| 2026-08-06 Option Award | 2026-08-10 6:24 pm | N/A 2036-08-05 | BlossomHill Therapeutics Inc. | BLSM | Oxnard Geoffrey Raymond Chief Medical Officer | 61,783 | $0 | 61,783 (Direct) | View |
| 2026-08-10 Conversion | 2026-08-10 6:23 pm | N/A N/A | BlossomHill Therapeutics Inc. | BLSM | Li Yishan Executive Chairman 10% Owner | 1,838,896 | $0 | 2,371,722 (Indirect) | View |
| 2026-08-06 Option Award | 2026-08-10 6:23 pm | N/A 2036-08-05 | BlossomHill Therapeutics Inc. | BLSM | Li Yishan Executive Chairman 10% Owner | 112,701 | $0 | 2,371,722 (Direct) | View |
| 2026-08-10 Conversion | 2026-08-10 6:22 pm | N/A N/A | BlossomHill Therapeutics Inc. | BLSM | Cui Jingrong Jean President and CEO 10% Owner | 1,838,896 | $0 | 2,935,226 (Indirect) | View |
| 2026-08-06 Option Award | 2026-08-10 6:22 pm | N/A 2036-08-05 | BlossomHill Therapeutics Inc. | BLSM | Cui Jingrong Jean President and CEO 10% Owner | 676,205 | $0 | 2,935,226 (Direct) | View |
Ownership | 2026-08-06 9:09 pm | N/A N/A | BlossomHill Therapeutics Inc. | BLSM | ORBIMED ADVISORS LLC OrbiMed Capital GP VIII LLC Director | 0 | $0 | 2,089,279 (Indirect) | View |
Ownership | 2026-08-06 8:48 pm | N/A 2036-05-17 | BlossomHill Therapeutics Inc. | BLSM | Schmid John P. Director | 0 | $0 | 67,620 (Direct) | View |
Ownership | 2026-08-06 8:47 pm | N/A N/A | BlossomHill Therapeutics Inc. | BLSM | GUJRATHI SHEILA Director | 0 | $0 | 90,160 (Direct) | View |
Ownership | 2026-08-06 8:46 pm | N/A 2035-08-15 | BlossomHill Therapeutics Inc. | BLSM | Agrawal Sundeep Director | 0 | $0 | 589,195 (Direct) | View |
Ownership | 2026-08-06 8:43 pm | N/A N/A | BlossomHill Therapeutics Inc. | BLSM | GORDON CARL L Director | 0 | $0 | 2,089,279 (Indirect) | View |
Ownership | 2026-08-06 8:39 pm | N/A N/A | BlossomHill Therapeutics Inc. | BLSM | Chen Bihua Cormorant Asset Management LP Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Cormorant Private Healthcare Fund V LP Cormorant Private Healthcare Fund VI LP Director 10% Owner | 0 | $0 | 3,301,534 (Indirect) | View |
Ownership | 2026-08-06 8:38 pm | N/A N/A | BlossomHill Therapeutics Inc. | BLSM | Liptak Vincent Paul General Counsel | 0 | $0 | 129,399 (Direct) | View |
Ownership | 2026-08-06 8:37 pm | N/A N/A | BlossomHill Therapeutics Inc. | BLSM | Oxnard Geoffrey Raymond Chief Medical Officer | 0 | $0 | 204,189 (Direct) | View |
Ownership | 2026-08-06 8:35 pm | N/A 2035-05-05 | BlossomHill Therapeutics Inc. | BLSM | Keyes Jason A Chief Financial Officer | 0 | $0 | 175,417 (Direct) | View |
Ownership | 2026-08-06 8:31 pm | N/A N/A | BlossomHill Therapeutics Inc. | BLSM | Li Yishan Executive Chairman 10% Owner | 0 | $0 | 3,973,138 (Direct) | View |
Ownership | 2026-08-06 8:30 pm | N/A N/A | BlossomHill Therapeutics Inc. | BLSM | Cui Jingrong Jean President and CEO 10% Owner | 0 | $0 | 3,973,138 (Direct) | View |